Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||
TABLE OF CONTENTS | ||||||||||||||||||||||||||||||||||||||||||||||
December 2015 Volume 15 Number 12 | ||||||||||||||||||||||||||||||||||||||||||||||
In this issue Research Highlights Reviews Perspectives
| ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS | Top | |||||||||||||||||||||||||||||||||||||||||||||
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer Philip A. Watson, Vivek K. Arora & Charles L. Sawyers p701 | doi:10.1038/nrc4016 This Review highlights emerging mechanisms of acquired resistance to agents targeting the androgen receptor in castration-resistant prostate cancer, which fall into the three broad categories of restored androgen receptor (AR) signalling, AR bypass signalling and complete AR independence. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||||||||||
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response Oakley C. Olson & Johanna A. Joyce p712 | doi:10.1038/nrc4027 Increased activity and aberrant localization of cysteine cathepsin proteases within the tumour microenvironment have potent roles in driving cancer progression. This Review discusses the roles of cathepsins and provides a roadmap for the rational integration of cathepsin-targeting agents into clinical treatment. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||||||||||
The mathematics of cancer: integrating quantitative models Philipp M. Altrock, Lin L. Liu & Franziska Michor p730 | doi:10.1038/nrc4029 This Review discusses mathematical modelling approaches in cancer research. These models can complement experimental and clinical studies, but can also challenge current paradigms, redefine our understanding of mechanisms driving tumorigenesis and shape future research. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||||||||||
PERSPECTIVES | Top | |||||||||||||||||||||||||||||||||||||||||||||
OPINION Precision medicine for cancer with next-generation functional diagnostics Adam A. Friedman, Anthony Letai, David E. Fisher & Keith T. Flaherty p747 | doi:10.1038/nrc4015 Genome-based cancer therapeutic matching is limited by incomplete biological understanding of the relationship between phenotype and cancer genotype. This Opinion article proposes that this limitation can be addressed by functional testing of live patient tumour cells exposed to potential therapies. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||||||||||
|
*2013 Journal Citation Report (Thomson Reuters, 2014) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment